ERBB2 and neoplasm: The BRCA1 protein is inactivated in most familial cases with BRCA1 mutations and is under-expressed in about 30% of sporadic breast cancers, mainly in high grade tumours and in “basal-like” or “triple-negative” (ER-, PR-, HER2-) tumours.